ZURICH, Feb 23(Reuters) - The Swiss blue-chip SMI was seen opening barely changed at 8,965 points on Friday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
The world’s second-biggest reinsurer reported better-than-expected annual net income despite huge claims during a disaster-heavy 2017 and said it was “carefully assessing” an investment approach from Japan’s Softbank .
Shares indicated up 1.4 percent.
For more news see
Sika reported better-than-expected 2017 net profit as France’s Saint-Gobain said it remained confident it would win its protracted takeover battle for the Swiss construction chemicals maker.
Temenos’s planned 1.4 billion pound ($1.95 billion)takeover of financial software peer Fidessa Group will enable faster sales growth at the British company, Temenos Chief Executive David Arnott told Reuters.
The president of a Swiss foundation that conducted a $232 million online fundraiser for the embattled Tezos cryptocurrency project has stepped down, the foundation said in a statement on Thursday.
* Liechtensteinische Landesbank AG to acquire 100 percent of shares of LB (Swiss) Investment Ltd
* Implenia AG is developing and building “rue du temple” project in Rolle worth around 80 million francs
* Basilea Pharmaceutica AG reports clinical phase 3 study start with antibiotic Ceftobiprole in skin infections
* Wisekey International Holding AG sees 2018 revenue up 38 percent
* Vontobel completes sale of Liechtenstein subsidiary to Kaiser Partner Privatbank
* The Swiss Takeover Commission ruled that a bank consortium’s financing package including pledging of shares in Schmolz + Bickenbach AG did not trigger a mandatory takeover offer.
Reporting by Zurich newsroom